Complement activation in Mycoplasma fermentans-induced mycoplasma clearance from infected cells: Probing of the organism with monoclonal antibodies against M161Ag

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1672-1680

  Kikkawa, Satomi ^a   Matsumoto, Misako ^a,b   Sasaki, Tsuguo ^c   Nishiguchi, Miyuki ^a   Tanaka, Kazuhiko ^a   Toyoshima, Kumao ^a   Seya, Tsukasa ^a,b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Organization for Pharmaceutical Safety and Research OPSR   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MONOCYTE; MYCOPLASMA HOMINIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT INFECTION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; COMPLEMENT ACTIVATION; COMPLEMENT C3; FEMALE; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MYCOPLASMA FERMENTANS; POLYMERASE CHAIN REACTION;

EID: 0033961617     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1672-1680.2000     Document Type: Article

References (42)

1. Atkinson, J P., and T. C. Farris. 1987. Separation of self from nonself in the complement system. Immunol. Today 8:212-213.
2. Bellinger-Kawahara, C., and M. A. Horwitz. 1990. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J. Exp. Med. 172:1201-1210.
3. Blanchard, A., and L. Montagnier. 1994. AIDS-associated mycoplasmas. Annu. Rev. Microbiol. 48:687-712.
4. Calcutt, M. J., M. F. Kim, A. B. Karpas, P. F. Muhlradt, and K. S. Wise. 1999. Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans. Infect. Immun. 67:760-771.
5. Erdei, A., G. Fust, and J. Gergely. 1991. The role of C3 in the immune response. Immunol. Today 12:332-337.
6. Feng, S. H., and S. C. Lo. 1994. Induced mouse spleen B-cell proliferation and secretion of immunogloblin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans. Infect. Immun. 62:3916-3921.
7. Hall, R. E., S. Agarwal, D. P. Kestler, J. A. Cobb, K. M. Goldstein, and N.-S. Chang. 1996. cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product. Biochem. J. 319:919-927.
8. Hawkins, R. E., L. S. Rickman, S. H. Vermund, and M. Carl. 1992. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood. J. Infect. Dis. 165: 581-585.
9. Holmskov, U., R. Malhotra, R. B. Sim, and J. C. Jensenius. 1994. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today 15:67-74.
10. Iida, K., K. Mitomo, T. Fujita, and N. Tamura. 1987. Characterization of three monoclonal antibodies against C3 with selective specificities. Immunology 62:413-417.
11. Janeway, C. A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13:11-16.
12. Katseni, V. L., C. B. Gilroy, B. K. Ryait, K. Ariyoshi, P. D. Bieniasz, J. N. Weber, and D. Taylor-Robinson. 1993. Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1. Lancet 341:271-273.
13. Kinoshita, T., M. E. Medof, R. Silber, and V. Nussenzweig. 1985. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med. 162:75-92.
14. Kirschning, C. J., H. Wesche, T. M. Ayres, and M. Rothe. 1998. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091-2097.
15. Köhler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
16. Lachmann, P. J. 1991. The control of homologous lysis. Immunol. Today 12: 312-315.
17. + lymphocytes by the AIDS-associated Mycoplasma. Science 251:1074-1076.
18. Matsumoto, M., and T. Seya. 1993. Homologous C3 deposition and homotypic cell adhesion in a human myeloid cell line, P39. Eur. J. Immunol. 23: 2270-2278.
19. Matsumoto, M., F. Yamashita, K. Iida, M. Tomita, and T. Seya. 1995. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3. J. Exp. Med. 181:115-125.
20. Matsumoto, M., J. Takeda, N. Inoue, T. Hara, M. Hatanaka, K. Takahashi, S. Nagasawa, H. Akedo, and T. Seya. 1997. A novel protein that participates in nonself discrimination of malignant cells by homologous complement. Nat. Med. 3:1266-1270.
21. Matsumoto, M., M. Nishiguchi, S. Kikkawa, H. Nishimura, S. Nagasawa, and T. Seya. 1998. Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes. J. Biol. Chem. 273:12407-12414.
22. Matsumoto, M., and T. Seya. 1999. M161Ag is a potent cytokine inducer with complement activating function. Int. J. Mol. Med. 3:291-295.
23. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397.
24. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298.
25. Mühlradt, P. F., and U. Schade. 1991. MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits. Infect. Immun. 59:3969-3974.
26. Mühlradt, P. F., M. Kieß, H. Meyer, R. Sußmuth, and G. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951-1958.
27. Ramos, O. F., G. Sarmay, E. Klein, E. Yefenof, and J. Gergely. 1985. Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum. Proc. Natl. Acad. Sci. USA 82:5470-5474.
28. Rawadi, G., S. Roman-Roman, M. Castedo, V. Dutilleul, S. Susin, P. Marchetti, M. Geuskens, and G. Kroemer. 1996. Effects of Mycoplasma fermentons on the myelomonocytic lineage: different molecular entities with cytokine-inducing and cytocidal potential. J. Immunol. 158:679-678.
29. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588-593.
30. Rottem, S., and Y. Naot. 1998. Subversion and exploitation of host cells by mycoplasmas. Trends Microbiol. 6:436-440.
31. Sasaki, T., Y. Sasaki, M. Kita, K. Suzuki, H. Watanabe, and M. Honda. 1992. Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains. J. Clin. Microbiol. 30: 2435-2440.
32. Schlesinger, L. S., and M. A. Horwitz. 1991. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J. Exp. Med. 174:1031-1038.
33. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
34. Seya, T., T. Hara, M. Matsumoto, and H. Akedo. 1990. Quantitative analysis of membrane cofactor protein (MCP) of complement: high expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J. Immunol. 145:238-245.
35. Susal, C., M. Kirschfink, M. Kropelin, V. Daniel, and G. Opelz. 1996. Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120. Blood 87:2329-2336.
36. Takizawa, F., S. Tsuji, and S. Nagasawa. 1996. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett. 397:269-272.
37. Tanaka, K., N. Shibata, K. Okamoto, T. Matsusaku, H. Taniguchi, and N. Shibata. 1986. Reorganization of myosin in surface-activated spreading platelets. J. Ultrastruct. Mol. Struct. Res. 97:165-186.
38. Taylor-Robinson, D., H. A. Davies, P. Sarathchandra, and P. M. Eurr. 1991. Intracellular location of mycoplasmas in cultured cells demonstrated by immunocytochemistry and electron microscopy. Int. J. Exp. Pathol. 72:705-714.
39. Wise, K. S. 1993. Adaptive surface variation in mycoplasmas. Trends Microbiol. 1:59-63.
40. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Chang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 395:284-288.
41. Yefenof, E., B. Asojö, and E. Klein. 1991. Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivity. Int. Immunol. 3:395-401.
42. Ziegler-Heitbrock, H. W. L., and R. Burger. 1987. Rapid removal of mycoplasma from cell lines mediated by a direct effect of complement. Exp. Cell Res. 173:388-394.